Servana (SERV) M&A Announcement summary

Deal rationale and strategic fit

• Acquisition aims to combine Medimi's and MedThings' strengths in digital medication management, expanding reach and enhancing patient safety through innovative solutions.

• Both companies share a vision to improve medication handling for patients, leveraging complementary technologies and market positions.

• MedThings' collaboration with Dignio and its launch of the Mobili e-dosett in Norway provide a strong foundation for Nordic market expansion.

Financial terms and conditions

• Medimi will acquire MedThings via a directed share issue, offering new Medimi shares valued at 68.9 MSEK to MedThings shareholders.

• The combined entity is valued at 97 MSEK, with 71% attributed to MedThings and 29% to Medimi.

• MedThings' agreement with Dignio is valued at 20 MSEK per year at full implementation over three years.

Synergies and expected cost savings

• The merger enables more efficient use of resources by consolidating operations, development, and support functions.

• Significant revenue and cost synergies are expected, supporting faster sales growth and improved efficiency.